23.64
전일 마감가:
$23.22
열려 있는:
$23.32
하루 거래량:
1.70M
Relative Volume:
1.03
시가총액:
$3.03B
수익:
$2.89B
순이익/손실:
$-33.80M
주가수익비율:
-87.56
EPS:
-0.27
순현금흐름:
$204.10M
1주 성능:
+11.09%
1개월 성능:
+6.20%
6개월 성능:
-8.37%
1년 성능:
-21.15%
Surgery Partners Inc Stock (SGRY) Company Profile
명칭
Surgery Partners Inc
전화
615-234-5900
주소
310 SEVEN SPRINGS WAY, BRENTWOOD, TN
SGRY을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
SGRY
Surgery Partners Inc
|
23.64 | 2.87B | 2.89B | -33.80M | 204.10M | -0.27 |
![]()
HCA
Hca Healthcare Inc
|
381.61 | 85.68B | 72.70B | 5.97B | 7.29B | 23.79 |
![]()
THC
Tenet Healthcare Corp
|
165.58 | 14.07B | 20.52B | 1.46B | 1.41B | 15.12 |
![]()
FMS
Fresenius Medical Care Ag Adr
|
24.07 | 13.80B | 20.92B | 666.06M | 1.85B | 1.1422 |
![]()
EHC
Encompass Health Corp
|
117.58 | 11.75B | 5.51B | 494.70M | 386.40M | 4.84 |
![]()
UHS
Universal Health Services Inc
|
172.30 | 10.53B | 16.08B | 1.20B | 1.06B | 17.82 |
Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-07-28 | 재개 | BofA Securities | Buy |
2024-12-16 | 개시 | BofA Securities | Buy |
2024-10-14 | 개시 | UBS | Buy |
2024-10-11 | 개시 | KeyBanc Capital Markets | Sector Weight |
2024-06-28 | 개시 | Macquarie | Outperform |
2024-03-06 | 개시 | Barclays | Equal Weight |
2023-11-14 | 업그레이드 | TD Cowen | Market Perform → Outperform |
2023-06-02 | 업그레이드 | BofA Securities | Neutral → Buy |
2023-05-12 | 개시 | Mizuho | Buy |
2023-04-21 | 개시 | Cantor Fitzgerald | Overweight |
2022-11-23 | 재확인 | RBC Capital Mkts | Outperform |
2022-06-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
2022-01-10 | 재개 | Citigroup | Buy |
2021-11-30 | 개시 | Barclays | Overweight |
2021-11-29 | 업그레이드 | Stifel | Hold → Buy |
2021-11-01 | 개시 | JP Morgan | Neutral |
2021-10-18 | 개시 | SVB Leerink | Outperform |
2021-09-10 | 개시 | Cowen | Market Perform |
2021-06-23 | 재개 | Stifel | Hold |
2020-09-17 | 재확인 | The Benchmark Company | Buy |
2020-04-27 | 업그레이드 | The Benchmark Company | Hold → Buy |
2020-03-03 | 다운그레이드 | The Benchmark Company | Buy → Hold |
2020-01-14 | 재확인 | The Benchmark Company | Buy |
2018-11-16 | 개시 | UBS | Neutral |
2018-09-18 | 업그레이드 | BofA/Merrill | Neutral → Buy |
2018-06-28 | 업그레이드 | Stifel | Sell → Hold |
2018-01-30 | 재확인 | The Benchmark Company | Buy |
2017-11-01 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
2017-08-09 | 다운그레이드 | KeyBanc Capital Mkts | Overweight → Sector Weight |
2017-08-09 | 다운그레이드 | Raymond James | Strong Buy → Mkt Perform |
2017-08-09 | 다운그레이드 | Stifel | Hold → Sell |
2017-04-24 | 재확인 | Stifel | Hold |
2017-03-10 | 다운그레이드 | Stifel | Buy → Hold |
2017-01-31 | 개시 | The Benchmark Company | Buy |
2016-06-10 | 개시 | KeyBanc Capital Mkts | Overweight |
2016-03-14 | 재확인 | RBC Capital Mkts | Outperform |
2015-10-27 | 개시 | Stifel | Buy |
2015-10-26 | 개시 | RBC Capital Mkts | Outperform |
2015-10-26 | 개시 | Raymond James | Strong Buy |
모두보기
Surgery Partners Inc 주식(SGRY)의 최신 뉴스
Surgery Partners, Inc. (NASDAQ:SGRY) Q2 2025 Earnings Call Transcript - MSN
Can Surgery Partners Inc. hit a new high this monthNeural Model for Stock Price Movement - Newser
Published on: 2025-08-08 23:19:54 - Newser
Long term hold vs stop loss in Surgery Partners Inc.High Confidence Strategy with Trend Alignment - Newser
Candlestick signals on Surgery Partners Inc. stock todaySmart Trade Forecast Based on Neural Logic - Newser
Insider Sales and Shareholder Confidence in Surgery Partners (SGRY): A Closer Look at CFO David Doherty's $1.11 Million Transaction - AInvest
Surgery Partners Insider Sold Shares Worth $1,110,814, According to a Recent SEC Filing - MarketScreener
Zurcher Kantonalbank Zurich Cantonalbank Decreases Stock Holdings in Surgery Partners, Inc. (NASDAQ:SGRY) - Defense World
Surgery Partners Reports Revenue Growth Amid Net Loss - TipRanks
Capitalizing on Undervalued Sectors: Why Brown & Brown and Surgery Partners Are Strategic Buys in a Shifting Market - AInvest
Surgery Partners, Inc. shares rise 1.76% intraday after UNC Health Rex Hospital and Brasseler Surgical collaboration. - AInvest
Surgery Partners Appoints New Chairman After Resignation - TipRanks
Surgery Partners outlines $200M acquisition target and signals leverage reduction focus amid robust organic growth - MSN
Surgery Partners stock rating reiterated by Benchmark on solid positioning - Investing.com South Africa
Surgery Partners: Q2 Earnings Snapshot - Huron Daily Tribune
Surgery Partners 2025 Q2 Earnings Strong Performance as Net Income Surges 58.1% - AInvest
Surgery Partners Inc (SGRY) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Surgery Partners (SGRY) Q2 Revenue Up 8% - The Motley Fool
Surgery Partners Inc. Earnings Call: Growth Amid Challenges - TipRanks
Surgery Partners, Inc. SEC 10-Q Report - TradingView
Earnings call transcript: Surgery Partners beats Q2 2025 earnings expectations By Investing.com - Investing.com Canada
Earnings call transcript: Surgery Partners beats Q2 2025 earnings expectations - Investing.com
Surgery Partners' Q2 2025: Unraveling Contradictions in M&A Strategy, Financial Goals, and Legislation Impact - AInvest
Surgery Partners Q2 Financial Results: Surpassing ExpectationsNews and Statistics - IndexBox
Surgery Partners beats Q2 expectations, reaffirms 2025 guidance - MSN
Surgery Partners (SGRY) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance
Surgery Partners (NASDAQ:SGRY) Surprises With Q2 Sales - Yahoo Finance
Surgery Partners Q2 Adjusted Earnings Fall, Revenue Rises; Reaffirms 2025 Revenue Guidance - MarketScreener
Surgery Partners Inc Reports Q2 2025 Revenue of $826.2M, Exceedi - GuruFocus
Surgery Partners reports Q2 adjusted EPS 17c, consensus 14c - TipRanks
Surgery Partners Inc earnings beat by $0.01, revenue topped estimates - Investing.com South Africa
Surgery Partners beats Q2 expectations, reaffirms 2025 guidance By Investing.com - Investing.com Canada
Surgery Partners beats Q2 revenue estimates, reaffirms guidance - MarketScreener
Surgery Partners, Inc. Reports Second Quarter 2025 Financial Results with 8.4% Revenue Growth and Reaffirms Full Year Guidance - Quiver Quantitative
Surgery Partners, Inc. Announces Second Quarter 2025 Results - TradingView
Earnings Flash (SGRY) Surgery Partners, Inc. Posts Q2 Adjusted EPS $0.17 per Share, vs. FactSet Est of $0.18 - MarketScreener
How to forecast Surgery Partners Inc. trends using time seriesStock Portfolio Risk and Return Analysis - Newser
Surgery Partners Inc (SGRY) Q2 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Does Surgery Partners Inc. fit your quant trading modelCapital Growth Plan for New Investors - Newser
Should I hold or sell Surgery Partners Inc. stock in 2025Unlock superior stock analysis tools - Jammu Links News
What makes Surgery Partners Inc. stock price move sharplyAchieve consistent high returns with low risk - Jammu Links News
Surgery Partners (SGRY) Reports Earnings Tomorrow: What To Expect - Yahoo Finance
Surgery Partners Inc. Stock Analysis and ForecastGet exclusive access to professional stock picks - Jammu Links News
What analysts say about Surgery Partners Inc. stockDynamic profit opportunities - Jammu Links News
What are the technical indicators suggesting about Surgery Partners Inc.Get real-time alerts on high-potential stocks - Jammu Links News
Is it the right time to buy Surgery Partners Inc. stockUnlock powerful insights from market experts - Jammu Links News
Allianz Asset Management GmbH Acquires New Position in Surgery Partners, Inc. (NASDAQ:SGRY) - Defense World
How many analysts rate Surgery Partners Inc. as a “Buy”Get alerts on the hottest stocks daily - Jammu Links News
What is Surgery Partners Inc. company’s growth strategyDiscover the next big stock winners - Jammu Links News
Surgery Partners Inc (SGRY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):